Crossmark

Design and construction of a microfluidics workstation for high-throughput multi-wavelength fluorescence and transmittance activated droplet analysis and sorting

Crossref DOI link: https://doi.org/10.1038/s41596-022-00796-2

Published Online: 2023-01-27

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Panwar, Jatin https://orcid.org/0000-0001-8271-2308
Autour, Alexis https://orcid.org/0000-0002-3786-0413
Merten, Christoph A. https://orcid.org/0000-0001-8790-4659
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (ME 3536/9-1, 01KI1822, ME 3536/9-1, 01KI1822)
License Information

Text and Data Mining valid from 2023-01-27

Version of Record valid from 2023-01-27
More Information

Article History

Received: 18 August 2021

Accepted: 9 November 2022

First Online: 27 January 2023

Competing interests

: C.A.M. is a cofounder of Veraxa Biotech and head of the TheraMe! consortium, both exploiting droplet microfluidic technology. However, the instrument described in this protocol is not offered commercially by any of these two entities.

Document is current

Any future updates will be listed below